💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for IDEXX Laboratories, Inc. (IDXX)
« Back to company indexIDXX Chatter Timeline
Stock Ticker for IDXX
Most Active Tweeters for IDXX
| User | Tweets |
|---|---|
| @TrollColors | 14 |
| @mediasentiment | 8 |
| @newsfilterio | 7 |
| @Tickeron | 5 |
| @optioncharts | 4 |
Recent Tweets for IDXX
 |
@LoRezTrader Watching $IDXX afterhours - welcome to the $700 Club ? https://t.co/VnV5S4EnLL August 4th 2021, 11:08pm |
 |
@sbwcws Idexx Laboratories assumed with an Outperform at Credit Suisse $IDXX August 4th 2021, 8:08pm |
 |
@ironstevie @FusionptCapital It looks a lot like $IDXX August 4th 2021, 6:08pm |
 |
@SkeleCap But $IDXX runs at 58.8% GMs. GS-441524 would be in the high 80s. A vet sales forcewouldn’t be cheap but every vet k… https://t.co/AIJCp62svP August 4th 2021, 6:08pm |
 |
@SwingTradeBot Rose Above Upper Bollinger Band today: $IDXX ... https://t.co/AyIukUGmib August 4th 2021, 5:08pm |
 |
@shortalgotrader $IDXX Waiting for short signal https://t.co/cHOF4URXXj https://t.co/UbrOWw7dT2 August 4th 2021, 10:08am |
 |
@ShortAlgoTrades $IDXX Trend is telling with the UltraAlgo! https://t.co/lNx8DRt793 August 4th 2021, 10:08am |
 |
@FlashAlert_me $IDXX [15s. delayed] filed SEC form 4: Director JUNIUS DANIEL M: Granted 10 of Common Stock at price $678.53 on 20… https://t.co/xGyPIuyOBC August 3rd 2021, 9:08pm |
 |
@mediasentiment $IDXX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 719 August 3rd 2021, 4:08pm |
|
@mediasentiment $IDXX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 716 August 3rd 2021, 4:08pm |
 |
@Tickeron $IDXX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on July 22, 2021. View odds f… https://t.co/0Mo1inugYz August 3rd 2021, 4:08pm |
 |
@Jarvis_Alerts $IDXX [IDEXX Laboratories]: Goldman Sachs Maintains Neutral Raises Price Target $550 --> 610 charts: courtesy of f… https://t.co/v7ehtwz3uR August 3rd 2021, 3:08pm |
 |
@quantisnow $IDXX ? Goldman Sachs reiterated coverage on IDEXX Laboratories with a new price target https://t.co/GkpIOKy025 30s delayed. August 3rd 2021, 2:08pm |
 |
@TrollColors TrollEvents $IDXX come from $US and #Gold based Trolling Nets. Assumptions: Stocks etc with Trend Changes more inte… https://t.co/CiXqlmSRaL August 3rd 2021, 11:08am |
|
@TrollColors TrollEvent $IDXX Observation: Not Prediction. All Data As Is: No Claims, Warranties; Data Time Delayed. Best viewed… https://t.co/kKiNafihhj August 3rd 2021, 11:08am |
|
@TrollColors TrollEvent: TrendilatorA Top >3, TrendilatorA Top >3; From $IDXX, IdexxLaboratories. $US TrollView Left, #Gold Trol… https://t.co/d6hOlHuEJu August 3rd 2021, 11:08am |
 |
@misstherage777 $IDXX formed a bearish divergence pre-earnings and finally had a decent pullback however there is a gap to fill @ $… https://t.co/TCVTgM1FVK August 3rd 2021, 3:08am |
|
@ShortAlgoTrades $IDXX Awaiting Buy Signal. Chart by UltraAlgo for #IDXX . https://t.co/n9MgWTABpW August 3rd 2021, 2:08am |
 |
@vimarblanco $IDXX Waiting for Buy signal on IDXX . https://t.co/arIhvOqNtY August 2nd 2021, 10:08pm |
|
@Jarvis_Alerts $IDXX [IDEXX Laboratories]: Barclays Maintains Overweight Raises Price Target $616 --> 750 charts: courtesy of fin… https://t.co/bUt2FYt08V August 2nd 2021, 2:08pm |
 |
@utradea_ $IDXX It is engaged in the development, manufacture, and distribution of products and services for the companion… https://t.co/PI0OLpK2MZ August 2nd 2021, 1:08pm |
|
@TrollColors TrollEvents $IDXX come from $US and #Gold based Trolling Nets. Assumptions: Stocks etc with Trend Changes more inte… https://t.co/Y6bwmoYx50 August 2nd 2021, 6:08am |
|
@TrollColors TrollEvent $IDXX Observation: Not Prediction. All Data As Is: No Claims, Warranties; Data Time Delayed. Best viewed… https://t.co/VdribLaBxm August 2nd 2021, 6:08am |
|
@TrollColors TrollEvent: TrendilatorB Top >3, TrendilatorA To; From $IDXX, IdexxLaboratories. $US TrollView Left, #Gold TrollVie… https://t.co/TdtNc41NIA August 2nd 2021, 6:08am |
 |
@marketcycles $IDXX | Idexx Laboratories $IDXX Trading Report (IDXX) https://t.co/yLGXFObQBj https://t.co/cxC7EH02Ir August 1st 2021, 4:08pm |
|
@ShortAlgoTrades $IDXX Awaiting for Buy Signal from UltraAlgo on IDXX https://t.co/5mwdG9Rmak August 1st 2021, 12:08pm |
|
@mediasentiment $IDXX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 672 August 1st 2021, 4:08am |
|
@Tickeron $IDXX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on July 22, 2021. View odds f… https://t.co/xB0xuCUNyU August 1st 2021, 3:08am |
 |
@Gambiste1 RT @CSIMarket: $IDXX #StockMarket #IdexxLaboratories issued most recent fiscal period Revenues on https://t.co/savSNTKlN1: IDXX announced s… July 31st 2021, 10:07pm |
 |
@CSIMarket $IDXX #StockMarket #IdexxLaboratories issued most recent fiscal period Revenues on https://t.co/savSNTKlN1: IDXX an… https://t.co/qotrismWhY July 31st 2021, 9:07pm |
 |
@newsfilterio Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $IDXX https://t.co/A7J1rsvral July 31st 2021, 6:07pm |
|
@vimarblanco $IDXX Waiting for Buy signal on IDXX https://t.co/HO1Ltw1ZrE July 31st 2021, 3:07pm |
 |
@Hail2stocks Couple of adds this month. $IDXX and $ETSY. Sold out of my vanguard dividend appreciation mutual fund and immedia… https://t.co/G7weMnjtDE July 31st 2021, 12:07pm |
 |
@falcontrades1 FalconTrades? alerted: $IDXX - Crossed 20 Day Moving Average on 07/30/21. Closing Price: $678.53.? #StocksToBuy July 31st 2021, 6:07am |
|
@newsfilterio IDEXX Laboratories Announces Second Quarter Results $IDXX https://t.co/B7GRIIYL5E July 31st 2021, 5:07am |
|
@newsfilterio IDEXX Laboratories beats Q1 estimates; FY21 guidance raise tops consensus $IDXX https://t.co/LNsRQVIHrN July 31st 2021, 4:07am |
|
@newsfilterio IDEXX Laboratories: Q2 Earnings Insights $IDXX https://t.co/oBotnY5Aqz July 31st 2021, 4:07am |
 |
@FundKapital $IDXX continues to be a secular winner, the stock has been a juggernaut and has not let up July 31st 2021, 1:07am |
 |
@SiteFocusHQ $IDXX Earnings Intelligence Analysis of recent earnings identified IDEXX Laboratories, Inc (NASDAQ: IDXX ) business… https://t.co/P4mvPe02Ku July 30th 2021, 10:07pm |
 |
@Risk75742306 $IDXX Ill be watching you... ? https://t.co/bLEsKN0i6i July 30th 2021, 10:07pm |
 |
@Xiphos_Trading $IDXX with the #HG too, $ORLY https://t.co/QsUTi6qADO July 30th 2021, 9:07pm |
 |
@kai109soccer RT @SeekingAlpha: $IDXX - IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2021 Results - Earnings Call Transcript. https://t.co/c8Un… July 30th 2021, 9:07pm |
 |
@rubinj57 Although $IDXX did have an Upside Reversal, it did not quite qualify as an Oops Reversal. https://t.co/zNqLuzNhB6 https://t.co/SGvo0DckJ4 July 30th 2021, 7:07pm |
 |
@SeekingAlpha $IDXX - IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2021 Results - Earnings Call Transcript.… https://t.co/JXbZYW8dXv July 30th 2021, 7:07pm |
 |
@StockTexts $IDXX IDEXX Laboratories, Inc. SEC Filing: Form 10-Q https://t.co/xW7afXdVBS July 30th 2021, 6:07pm |
 |
@EdgarInsider Filing for 10-Q [Quarterly Report] has been made with the SEC: $IDXX IDEXX LABORATORIES INC /DE https://t.co/5W1QDaCmGN July 30th 2021, 6:07pm |
|
@quantisnow $IDXX ? SEC Form 10-Q filed by IDEXX Laboratories, Inc. https://t.co/G9FWE2Uzc8 30s delayed. July 30th 2021, 6:07pm |
 |
@investor_feed $IDXX 10-Q Idexx Laboratories (30 Jul, 2:48pm) ? 2021 Q2 Earnings https://t.co/4aeDSCgiDC #IDXX #10Q #IdexxLaboratories #Earnings July 30th 2021, 6:07pm |
 |
@EarningsAlley IDEXX Laboratories, Inc. $IDXX held an earnings call on 7/30/2021. Here are the highlights: July 30th 2021, 6:07pm |
 |
@DeleuzeEmmanuel RT @bluff_capital: $IDXX U.S. Companion Animal Practice Growth Update https://t.co/k9RXA4pDa7 July 30th 2021, 5:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?